-
03.12.2025 | The looming antibiotic emergency and why the time for global action is now
THE TELEGRAPH | The fight against antimicrobial resistance is reaching a critical moment: drug-resistant infections are outpacing our ability to treat them.
-
03.11.2025 | Could microplastics be fueling antibiotic resistance?
THE INDEPENDENT | Boston researchers found that bacteria exposed to microplastics became resistant to multiple types of common antibiotics.
-
03.05.2025 | Scientists discover new part of the immune system
BBC | A new part of the immune system has been discovered and it is a goldmine of potential antibiotics, scientists have said.
-
03.03.2025 | Study finds ‘pronounced’ levels of antimicrobial resistance in cancer patients
CIDRAP | A systematic review and meta-analysis found a high level of antimicrobial resistance (AMR) in bacteria isolated from cancer patients, researchers reported late last week in BMC Infectious Diseases.
-
02.12.2025 | Philanthropic partnership launches new initiative tackling antimicrobial resistance, the third-leading cause of death globally, by fast-tracking discovery of new treatments
GATES FOUNDATION | Initiative marks first investment of global health partnership between the Gates Foundation, Novo Nordisk Foundation, and Wellcome to address global health challenges that disproportionately impact people living in low- and middle-income countries.
-
02.08.2025 | AbbVie wins FDA approval for new antibiotic to treat complex intra-abdominal infections
ENDPOINTS NEWS | The FDA approved AbbVie and Pfizer’s drug Emblaveo in combination with an older antibiotic to treat complicated intra-abdominal infections.
-
01.29.2025 | Antibiotic resistance is here. Millions of people are dying.
GLOBAL PRESS JOURNAL | Scientists and doctors can't keep up with the tidal wave of people whose bodies don't respond to basic antimicrobial treatment.
-
01.24.2025 | Biotechs ‘cry for help’ to fix antibiotics market failure
POLITICO | Scientists trying to bring new antibiotics out of the lab and see them administered to patients are being forced to shelve their promising therapies due to a chronic market failure.
-
01.23.2025 | How global collaboration is addressing the growing threat of antimicrobial resistance
WORLD ECONOMIC FORUM | Antimicrobial resistance (AMR) is one of the most pressing global public health and development threats of our time. When infection-causing microbes such as bacteria develop resistance to the medicines we use to treat them, it affects every community and every country across all regions and income levels.
-
01.22.2025 | Charting the path to tackle AMR: How to create an inclusive and impactful independent panel
CENTER FOR GLOBAL DEVELOPMENT | In 2024, antimicrobial resistance (AMR) took center stage at the United Nations General Assembly’s High-Level Meeting for the second time. A key decision: countries charged the Quadripartite to establish an independent panel for evidence for action against AMR by 2025.
-
01.22.2025 | ‘Every blast is an open wound’: how the chaos of war breeds deadly superbugs that spread around the world
THE CONVERSATION | The war in Gaza will leave its mark in many ways, long after the recently negotiated ceasefire deal between Israel and Hamas.
-
01.21.2025 | War clinics in Ukraine witness sharp rise in drug-resistant infections
BBC | When Pte Oleksander Bezverkhny was evacuated to the Feofaniya Hospital in Kyiv, few believed he would live. Then, doctors discovered that his infections were resistant to commonly-used antibiotics – and the already daunting task of saving his life became almost hopeless.
-
01.19.2025 | What if a virus could reverse antibiotic resistance?
ASBMBTODAY | Peering through his microscope in 1910, Franco-Canadian microbiologist Félix d'Hérelle noticed some “clear spots” in his bacterial cultures, an anomaly that turned out to be viruses preying on the bacteria. Years later, d'Hérelle would come to use these viruses, which he called bacteriophages, to treat patients plagued with dysentery after World War I.
-
01.15.2025 | Report highlights how COVID hindered the fight against antimicrobial resistance
CIDRAP | A new report from the Department of Health and Human Services (HHS) suggests that a number of interrelated factors hampered the ability of US hospitals to control antimicrobial resistance (AMR) during the COVID-19 pandemic.
-
01.10.2025 | Fighting a global threat: How the Chamber is combating antimicrobial resistance
U.S. CHAMBER OF COMMERCE | Coordinated global action, with strong leadership from Capitol Hill, is critical to combating the threat of antimicrobial resistance (AMR).
-
01.09.2025 | ‘Nobody cares’: the women living with untreatable UTIs
THE BUREAU OF INVESTIGATIVE JOURNALISM | Sweeping antibiotic use in the US means a once innocuous condition now leaves some suffering for years.
-
01.05.2025 | Antibiotic emergency ‘could claim 40 million lives in next 25 years’
THE GUARDIAN | As superbugs spread across the globe, death rates from antimicrobial resistance are set to double, says England’s former chief medical officer.
-
01.01.2025 | Turning the phage on drug-resistant bacteria
THE ECONOMIST | Bacteriophages, or “phages”, are viruses that can infect bacteria. With the number of bacteria that can evade antibiotics growing worryingly large, interest in using phages as therapies against drug-resistant infections has been rising.
Toggle navigation